Mach7 (ASX:M7T) share price slides on mixed FY21 result

The company's share price ended the day on a down note.

| More on:
a concerned medical doctor examines an Xray from an imaging machine in a hospital setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Mach7 Technologies Ltd (ASX: M7T) share price ended Monday's market session in negative territory. This comes after the healthcare imaging platform provider released its full-year results for the 2021 financial year.

At the closing bell, Mach7 shares finished down 3.52% to 96 cents.

Mach7 share price backtracks despite record sales orders

The Mach7 share price fell today following the company's mixed result for the 12 months ending 30 June 2021. Here are some of the key highlights:

  • Sales orders (total contract value) of $25.6 million, up 95% on the prior corresponding period (FY20 $13.14 million);
  • Total revenue of $19 million, up 1% (FY20 $18.9 million);
  • Earnings before interest, tax, depreciation and amortisation (EBITDA) loss of $1.8 million, down 155% (FY20 EBTIDA profit of $3.3 million); and
  • Net loss after tax of $9.3 million, down 5,627% (FY20 $0.16 million).

What happened in FY21 for Mach7?

Mach7 delivered its most successful sales order increase on the back of 2 large contracts by premier hospital networks. They included Trinity Healthcare and Adventist Healthcare, realising a combined value of $13.2 million.

The sales order mix consisted of 20% Software-as-a-Service (SaaS) subscriptions, a significant improvement on the 3% in FY20. Mach7's eUnity product, acquired in July 2020, predominately fuelled the growth.

The remaining sales orders were made up of capital sales (perpetual or term licenses) and services contracts (migrations). They represented 72% and 8%, respectively.

Mach7's annual recurring revenue (ARR) soared by more than 80% to $10.9 million, accounting for now 57% of total revenue. Professional services revenue was stable at $2.2 million, with capital software license fee revenue decreasing by 42% to $6.0 million. The latter is due to a phased rollout which will see a solid order book for FY22.

At the EBITDA level, currency exchange losses mostly affected the result. Notwithstanding currency movements, EBITDA would have made a small loss of $0.7 million. This is attributed to incorporating Client Outlook in 202, and the delay of sales orders until FY22.

What's next for Mach7 in FY22?

Looking ahead, Mach7 advised it remains on track to achieve revenue of $27 million for the current calendar year.

This is underpinned by the first-half recording revenues of $12 million, as well as the 50% current ARR run-rate of $13.4 million. In addition, the sales and service book valued at $8.3 million is expected to be recognised in the second half.

Mach7 stated that with these revenues, it will be generating a positive EBITDA.

Should you invest $1,000 in Auscann Group right now?

Before you buy Auscann Group shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Auscann Group wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Five retirees do a conga line dance on the beach celebrating the special dividend announced by Grange Resources today
Broker Notes

Why Macquarie thinks the NZ retirement village sector could be an emerging opportunity for ASX investors

Oceania Healthcare and Summerset could quietly emerge as high-upside plays for patient ASX investors.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

5 high-conviction ASX 200 shares to buy

Brokers are tipping these shares as buys. Here’s what they rate highly.

Read more »

A woman in a business suit sits at her desk with gold bars in each hand while she kisses one bar with her eyes closed. Her desk has another three gold bars stacked in front of her. symbolising the rising Northern Star share price
Gold

How this ASX All Ords gold stock turned $10,000 into $78,740 in just one year

The ASX All Ords gold miner has raced higher over the year. Let’s find out how.

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Share Market News

US-China tariff deal sparks strong week for ASX 200

Energy shares ripped 5.77% higher while the ASX 200 lifted 1.37% over the five days.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Opinions

2 ASX 200 shares that I think are still bargains after the market rally

These businesses look like attractive opportunities. Here’s why…

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed a happy end to the trading week this Friday.

Read more »

Happy woman working on a laptop.
Broker Notes

Macquarie's best ASX 200 share picks in each of the 11 market sectors

Looking for stock-buying opportunities?

Read more »